As oral therapies become central in ovarian cancer care, cancer nurses are key to optimising patient outcomes through proactive monitoring and side effect management.
NSW cancer nurses are encouraged to support the new Gestational Trophoblastic Disease (GTD) Multidisciplinary Team (MDT) Clinical Service Pilot, launching in July 2025.
